CIPLACipla
Pharma · Pharmaceuticals · NSE · as of 2026-10-28 (delayed ~30 min in market hours)
Cipla operates in the Pharmaceuticals space within the Pharma sector.
₹1,365.60
▲ 1.16%Average
Mkt Cap
₹1.10L Cr
P/E
32.8
P/B
3.2
Div Yield
0.89%
52W High
₹1,578.49
52W Low
₹1,154.87
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)1,09,916.10
P/E32.75
P/B3.24
PEG—
ROE %11.30
ROCE %13.80
Debt / Equity0.02
EPS41.70
Revenue Growth %3.50
Profit Growth %-39.20
Dividend Yield %0.89
Promoter Holding %31.14
FII Holding %44.46
DII Holding %—
Beta0.09
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
HOLDConviction 59%
The picture
- • Debt/Equity: 0.02
- • Valuation vs sector: P/E 32.8 vs sector 36.1
- • RSI: 56
- • MACD: bullish
- • Price vs EMA21: above
- • 6-month vs NIFTY: +9.0% relative
- • Pullback to 21-EMA signal (setup quality 66%)
Bull case
- • Debt/Equity: 0.02
- • Valuation vs sector: P/E 32.8 vs sector 36.1
- • RSI: 56
- • MACD: bullish
Bear case
- • Revenue growth: 3.5% YoY
- • Profit growth: -39.2% YoY
- • Price vs SMA50: below
- • Supertrend: bearish
Key risks
- • Weak fundamentals — technical strength may not sustain
- • Revenue growth: 3.5% YoY
- • Profit growth: -39.2% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹1,365.60
Stop Loss
₹1,294.28
risk 5.2%
Target 1 (1.5R)
₹1,472.59
+7.8%
Target 2 (3R)
₹1,579.57
+15.7%
Support (20d)
₹1,292.00
Resistance (52w)
₹1,578.49
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹71.32/share
ATR (volatility)
₹28.53
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹28.53). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental42
Technical61
Momentum44
Risk (safety)73